With COVID-19 Delta Variant Raging, UPMC Seeks People In Pennsylvania For Monoclonal Antibody Study
wesa.fm - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wesa.fm Daily Mail and Mail on Sunday newspapers.
Another local medical provider is offering an intravenous antibody therapy that may help COVID-19 patients avoid hospital stays and recover more quickly with fewer complications.
The Wright Center for Community Health is now operating a Scranton outpatient infusion clinic administering the monoclonal antibody bamlanivimab, which received emergency use authorization as a COVID-19 treatment in November.
âMonoclonal antibodies are laboratory-made proteins that mimic the immune systemâs ability to fight off harmful pathogens like viruses,â according to the U.S. Food and Drug Administration. Developed by the pharmaceutical firm Eli Lilly and Co., bamlanivimab is a monoclonal antibody specifically directed against the spike protein of SARS-CoV-2, the virus that causes COVID-19. Itâs âdesigned to block the virusâ attachment and entry into human cells,â according to the FDA.
In November, the FDA approved emergency authorization for monoclonal antibody treatments. Author: Nikki Krize Updated: 4:32 PM EST February 10, 2021
DANVILLE, Pa. Sharon Yurkiewicz of Bear Gap came down with COVID-19 in late December. I really had no energy. I was fatigued, really couldn t do anything, Yurkiewicz said.
Shortly after Yurkiewicz was diagnosed with the coronavirus, her doctor at Geisinger called her about an antibody infusion. In November, the FDA approved emergency authorization for monoclonal antibody treatments. They mimic the body s ability to fight the infection. They essentially provide a boost to fight the infection, Dr. Keith Boell said.
Monoclonal antibodies are made in a laboratory and are given to patients directly through an infusion.
vimarsana © 2020. All Rights Reserved.